Trilogy Capital’s Frontline FRO Stock Holding History

Trilogy Capital’s Portfolio FRO Stock Details FRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5	Closed	–	–	285
2018 Q3	$0	Hold	5	–	–	﹤0.01%	622
2018 Q2	$0	Hold	5	–	–	﹤0.01%	590
2018 Q1	$0	Buy	+5	New	+$22	﹤0.01%	490

Other funds holding FRO

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OAMG

Odey Asset Management Group London, United Kingdom $381M AUM 45.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM Holding Zurich, Switzerland $1.57B AUM 25.73% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Trilogy Capital's FRO Position: Q4 2018 in Review

Trilogy Capital sold out of Frontline (FRO) in Q4 2018, closing a stake of 5 shares.

Trilogy Capital first reported a position in FRO in Q1 2018 and held it in 3 quarters. The position peaked at $0 in Q3 2018. 92 funds tracked by Wall St. Rank hold FRO as of Q4 2018.

Trilogy Capital reported no remaining Frontline position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 5 Frontline shares in Q4 2018.
Trilogy Capital first reported a position in Frontline in Q1 2018 and held it in 3 quarters.
Trilogy Capital's Frontline position peaked at $0 in Q3 2018.
92 funds tracked by Wall St. Rank held Frontline as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.